EligibleTrials

At High-risk for Pre-eclampsia After Assisted Reproductive Technology

Recruiting · NCT05746793 · Observational (researchers observe without assigning treatment) · Lead sponsor: CRG UZ Brussel

View the official record on ClinicalTrials.gov →
Hypertension

Interventions studied

Baseline questionnaireBlood pressure measurementMOCK frozen embryo transfer preparative cycle.Peripheral phlebotomyTransabdominal ultrasoundUrine collectioncardiac work-upcollection of menstrual bloodendometrium biopsynutritional and metabolic work-up

What this trial is about

The overarching goal of the project is to unravel PE etiopathogenesis in high-risk patients (PCOS patients and oocyte acceptors) after assisted reproductive technology (ART) to individualize prenatal care following ART and to determine potential targets for new PE prevention options decreasing the morbidity/mortality caused by this pathology. More specifically, the following objectives/work packages (WPs) are put forward: * WP1 - PRECONCEPTION: Identify preconceptional maternal characteristics associated with in-creased risk of PE in ART patients (1a) and investigate the potential role of the endometrium prior to pregnancy (1b). * WP2 - DURING PREGNANCY: Evaluate the Fetal Medicine Foundation's (FMF) first trimester PE screening in selected high-risk groups post ART to explore the clinical benefit in this specific context (2a) and investigate the association between parameters during the pregnancy and PE development post-ART. * WP3 - AT DELIVERY: Identifying placental molecular pathways associated with PE post-ART.

Who can take part

Age range
18 Years to 48 Years
Sex
Female
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.